Kizzmekia S. Corbett

This study uses flow virometry to analyze spike antigenicity of endemic human coronaviruses, revealing cell line-dependent differences and heterogeneity not captured by bulk assays.

This paper evaluates the CytoFLEX nano flow cytometer's performance for detecting surface proteins on HIV and extracellular vesicles, finding it has higher scatter sensitivity and detects smaller particles and EV populations compared to a conventional flow cytometer.

This paper designs and evaluates nanoparticle vaccines with optimized linkers to enhance cross-reactive antibody responses against coronaviruses and other viral families.

This study identifies gram-positive bacterial cell wall components, such as peptidoglycan and lipoteichoic acid, as inhibitors of HSV-1 and HSV-2 infection in vitro and in a mouse model.

This study identifies mAbs targeting HCoV-HKU1 spike protein and shows that receptor-binding site recognition alone does not predict neutralization in primary cells.

The paper designs multiclade coronavirus spike immunodominant domain nanoparticles that elicit broad antibody responses against multiple EhCoVs and SARS-CoV-2 variants in mice.

This study maps polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 vaccines using EMPEM, revealing the NTD supersite as an immunodominant epitope vulnerable to variant mutations.